Achieve Life Sciences, Inc. (ACHV)
$7.06-4.72%Close
SELLBEAR · day 3
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $725M
- Beta
- 2.31
- P/E (TTM)
- -4.54
- Short % float
- 19.98%
- Days to cover
- 10.9
- SI change
- +9.3%
- 1W
- +0.71%
- 1M
- +0.00%
- vs SPY 1W
- +0.29%
- vs SPY 1M
- -2.06%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ACHV?
- LOPJLB’s latest quantitative signal on Achieve Life Sciences, Inc. (ACHV) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is ACHV in?
- Achieve Life Sciences, Inc. (ACHV) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Achieve Life Sciences, Inc. (ACHV) do?
- Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom. Cytisinicline is a naturally occurring alkaloid, which functions by engag…